The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Open accessAbstract
BACKGROUND: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults. METHODS: We enrolled 38,546 adults 60 years of age or older in a randomized, double-blind, placebo-controlled trial of an investigational live attenuated Oka/Merck VZV vaccine ("zoster vaccine"). Herpes zoster was diagnosed according to clinical and laboratory criteria. The pain and discomfort associated with herpes zoster were measured repeatedly for six months. The primary end point was the burden of illness due to herpes zoster, a measure affected by the incidence, severity, and duration of the associated pain and discomfort. The secondary end point was the incidence of postherpetic neuralgia. RESULTS: More than 95 percent of the subjects continued in the study to its completion, with a median of 3.12 years of surveillance for herpes zoster. A total of 957 confirmed cases of herpes zoster (315 among vaccine recipients and 642 among placebo recipients) and 107 cases of postherpetic neuralgia (27 among vaccine recipients and 80 among placebo recipients) were included in the efficacy analysis. The use of the zoster vaccine reduced the burden of illness due to herpes zoster by 61.1 percent (P<0.001), reduced the incidence of postherpetic neuralgia by 66.5 percent (P<0.001), and reduced the incidence of herpes zoster by 51.3 percent (P<0.001). Reactions at the injection site were more frequent among vaccine recipients but were generally mild. CONCLUSIONS: The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A live-attenuated vaccine is available, which has been shown to reduce the incidence of herpes zoster by 51.3% (95% CI: 44.2–57.6) and of post-herpetic neuralgia, a severe complication occurring frequently in the elderly, by 66.5% (95% CI: 44.5–79.2) in the vaccinated population compared to placebo [170].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
In the citing paper
“The protective effect against post-herpetic neuralgia was independent of age, whereas clinical efficacy against herpes zoster declined to only 27.6% in persons older than 69 years.”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,389
Comparative analysis of two rates
Miettinen, O. S., & Nurminen, M. M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,111
Population-Based Study of Herpes Zoster and Its Sequelae
Ragozzino, M. W., Melton, L. J., Kurland, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 921
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Self-citationTesting the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire
Brazier, J. E., Jones, N., & Kind, P. (1993) · Quality of Life Research · doi:10.1007/bf00435221 · Cited by 707
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Self-citationThe Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430150071008 · Cited by 618
Flagged first, then by citations
Research works printed but not linked: 2
- Hope-Simpson RE, 1965, Proc R Soc Med, 58, 9
- Hope-Simpson RE, 1975, J R Coll Gen Pract, 25, 571
Cited by
Sorted by citations
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R. L., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,271
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Tomblyn, M. R., Chiller, T. M., Einsele, H., Gress, R. E., Sepkowitz, K. A., Storek, J., Wingard, J. R., Young, J. H., & Boeckh, M. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,832
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Neuropathic Pain: From Mechanisms to Treatment
Finnerup, N. B., Kuner, R., & Jensen, T. S. (2020) · Physiological Reviews · doi:10.1152/physrev.00045.2019 · Cited by 1,727
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Self-citationDworkin, R. H., O'connor, A., Audette, J. F., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., Lebel, A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,342
Self-citationRecommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Self-citationHarpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,018
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 943
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C. F., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 967
Self-citationYawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 866
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
Self-citationFurer, V., Rondaan, C., Heijstek, M. W., Agmon‐Levin, N., van Assen, S., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215882 · Cited by 859
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 737
Roush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
Dooling, K. L., Guo, A., Patel, M., Lee, G. M., Moore, K. L., Belongia, E. A., & Harpaz, R. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6703a5 · Cited by 633
van Assen, S., Agmon‐Levin, N., Elkayam, O., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137216 · Cited by 631
Scientific and Medical Aspects of Ozone Therapy. State of the Art
Bocci, V. A. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.08.006 · Cited by 676
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 583
Johnson, R. W., & Rice, A. S. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1403062 · Cited by 575
The neurotropic herpes viruses: herpes simplex and varicella-zoster
Steiner, I., Kennedy, P. G. E., & Pachner, A. R. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70267-3 · Cited by 572
Heininger, U., & Seward, J. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69561-5 · Cited by 562
An Interdisciplinary Expert Consensus Statement on Assessment of Pain in Older Persons
Hadjistavropoulos, T., Herr, K., Turk, D. C., Fine, P. G., Dworkin, R. H., Helme, R. D., Jackson, K. C., Parmelee, P. A., Rudy, T. E., Beattie, B. L., et al. (2006) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31802be869 · Cited by 570
Self-citationImmunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 543
Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., Huebner, R. E., Janoff, E. N., Justice, A. C., Kuritzkes, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590150 · Cited by 539
Self-citationMolecular mechanisms of varicella zoster virus pathogenesis
Zerboni, L., Sen, N., Oliver, S. L., & Arvin, A. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3215 · Cited by 479
Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
Liesegang, T. J. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 476
The Brief Pain Inventory User Guide
Cleeland, C. S. (2009) · Cited by 464
Infection Risk and Safety of Corticosteroid Use
Youssef, J., Novosad, S., & Winthrop, K. L. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.004 · Cited by 478
Neuropathic pain: a practical guide for the clinician
Gilron, I. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060146 · Cited by 451
Aging of the immune system: Focus on inflammation and vaccination
Pinti, M., Appay, V., Campisi, J., Frasca, D., Fülöp, T., Sauce, D., Larbi, A., Weinberger, B., & Cossarizza, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201546178 · Cited by 439
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Schmader, K. E., Levin, M. J., Gnann, J. W., McNeil, S., Vesikari, T., Betts, R. F., Keay, S. K., Stek, J. E., Bundick, N. D., Su, S.-C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir970 · Cited by 430
Self-citationHerpes Zoster (Shingles) and Postherpetic Neuralgia
Sampathkumar, P., Drage, L. A., & Martin, D. P. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.274 · Cited by 428
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G. C., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 406
Self-citationBiology of Immune Responses to Vaccines in Elderly Persons
Weinberger, B., Herndler‐Brandstetter, D., Schwanninger, A., Weiskopf, D., & Grubeck‐Loebenstein, B. (2008) · Clinical Infectious Diseases · doi:10.1086/529197 · Cited by 392
Clinical Features of Varicella-Zoster Virus Infection
Kennedy, P. G. E., & Gershon, A. A. (2018) · Viruses · doi:10.3390/v10110609 · Cited by 368
Self-citationThe structural basis of herpesvirus entry
Connolly, S. A., Jardetzky, T. S., & Longnecker, R. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00448-w · Cited by 366
Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
Levin, M. J., Oxman, M. N., Zhang, J. H., Johnson, G. R., Stanley, H., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Smith, J. G., Clair, J. S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528696 · Cited by 355
Self-citationHerpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Winthrop, K. L., Yamanaka, H., Valdez, H., Mortensen, E., Chew, R. D., Krishnaswami, S., Kawabata, T. T., & Riese, R. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38745 · Cited by 355
A systematic review and meta-analysis of risk factors for postherpetic neuralgia
Forbes, H. J., Thomas, S. L., Smeeth, L. L., Clayton, T. C., Farmer, R. E., Bhaskaran, K., & Langan, S. (2015) · Pain · doi:10.1097/j.pain.0000000000000307 · Cited by 353
Li, G., Yu, M., Lee, W.-W., Tsang, M., Krishnan, E., Weyand, C. M., & Goronzy, J. J. (2012) · Nature Medicine · doi:10.1038/nm.2963 · Cited by 349
Risk Factors for Herpes Zoster Infection: A Meta-Analysis
Marra, F., Parhar, K., Huang, B., & Vadlamudi, N. K. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa005 · Cited by 337
The development of vaccines: how the past led to the future
Plotkin, S. A., & Plotkin, S. L. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2668 · Cited by 334
Sleep Disturbance and Depression Recurrence in Community-Dwelling Older Adults: A Prospective Study
Cho, H. J., Lavretsky, H., Olmstead, R., Levin, M. J., Oxman, M. N., & Irwin, M. R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121882 · Cited by 318
Self-citationDrolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R. W., Oxman, M. N., Patrick, D. M., Blanchette, C., & Mansi, J. A. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091711 · Cited by 310
Self-citationProspects for a vaccine against the hepatitis C virus
Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312
Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis
Kawai, K., & Yawn, B. P. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.10.009 · Cited by 312
Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis of Disease, and Latency
Mueller, N. H., Gilden, D. H., Cohrs, R. J., Mahalingam, R., & Nagel, M. A. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.011 · Cited by 314
Clinical Implications of Aging Skin
Farage, M. A., Miller, K. W., Berardesca, E., & Maibach, H. I. (2009) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200910020-00001 · Cited by 307
Aging, Immunity, and the Varicella–Zoster Virus
Arvin, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058091 · Cited by 305
High, K. P., Bradley, S., Gravenstein, S., Mehr, D. R., Quagliarello, V., Richards, C. L., & Yoshikawa, T. T. (2008) · Clinical Infectious Diseases · doi:10.1086/595683 · Cited by 302
A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging
Lanna, A., Gomes, D. C. O., Muller-Durovic, B., McDonnell, T., Escors, D., Gilroy, D. W., Lee, J. H., Karin, M., & Akbar, A. N. (2017) · Nature Immunology · doi:10.1038/ni.3665 · Cited by 284
Long-term Persistence of Zoster Vaccine Efficacy
Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R. F., Gelb, L., Guatelli, J., Harbecke, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu918 · Cited by 293
Self-citationJohnson, R. W., Álvarez-Pasquín, M. J., Bijl, M., Franco, E., Gaillat, J., Clara, J. G., Labétoulle, M., Michel, J., Naldi, L., Sanmartí, L. S., et al. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615599151 · Cited by 290
Influence of immune aging on vaccine responses
Gustafson, C. E., Kim, C., Weyand, C. M., & Goronzy, J. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.017 · Cited by 292
Antiviral treatment for preventing postherpetic neuralgia
Chen, N., Li, Q., Yang, J., Zhou, M., Zhou, D., & He, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006866.pub3 · Cited by 289
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., Breuer, J., Carrington, D., Martin, M., & Remy, V. F. M. (2008) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Zhang, J., Xie, F., Delzell, E., Chen, L., Winthrop, K. L., Lewis, J. D., Saag, K. G., Baddley, J. W., & Curtis, J. R. (2012) · JAMA · doi:10.1001/jama.2012.7304 · Cited by 283
Self-citationHerpes zoster: Epidemiology, natural history, and common complications
Weinberg, J. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.046 · Cited by 278
Metabolic Phenotypes of Response to Vaccination in Humans
Li, S., Sullivan, N., Rouphael, N., Yu, T., Banton, S., Maddur, M. S., McCausland, M. M., Chiu, C., Canniff, J. D., Dubey, S. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.026 · Cited by 277
Self-citationQuantification of risk factors for herpes zoster: population based case-control study
Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L. L., Clayton, T. C., & Langan, S. (2014) · BMJ · doi:10.1136/bmj.g2911 · Cited by 283
Weinberg, A., Zhang, J. H., Oxman, M. N., Johnson, G. R., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Clair, J. S., Smith, J. G., Stanley, H. A., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605611 · Cited by 271
Self-citationBastidas, A., de la Serna, J., Idrissi, M. E., Oostvogels, L., Quittet, P., López‐Jiménez, J., Vural, F., Pohlreich, D., Zuckerman, T., Issa, N. C., et al. (2019) · JAMA · doi:10.1001/jama.2019.9053 · Cited by 269
Epidemiology of Neuropathic Pain and Its Impact on Quality of Life
Smith, B. H., & Torrance, N. (2012) · Current Pain and Headache Reports · doi:10.1007/s11916-012-0256-0 · Cited by 279
A natural experiment on the effect of herpes zoster vaccination on dementia
Eyting, M., Xie, M., Michalik, F., Heß, S., Chung, S., & Geldsetzer, P. (2025) · Nature · doi:10.1038/s41586-025-08800-x · Cited by 273
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Tseng, H. F. (2011) · JAMA · doi:10.1001/jama.2010.1983 · Cited by 238
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination
Yun, H., Yang, S., Chen, L., Xie, F., Winthrop, K. L., Baddley, J. W., Saag, K. G., Singh, J. A., & Curtis, J. R. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39670 · Cited by 233
Weinberg, A., & Levin, M. J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_31 · Cited by 232
Self-citationSchmader, K. E., Oxman, M. N., Levin, M. J., Johnson, G. R., Zhang, J. H., Betts, R. F., Morrison, V. A., Gelb, L. D., Guatelli, J. C., Harbecke, R., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis638 · Cited by 230
Self-citationPathogenesis and Current Approaches to Control of Varicella-Zoster Virus Infections
Gershon, A. A., & Gershon, M. D. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00052-13 · Cited by 240
Self-citationVaccination in the elderly: an immunological perspective
Chen, W. H., Kozlovsky, B. F., Effros, R. B., Grubeck‐Loebenstein, B., Edelman, R., & Sztein, M. B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.002 · Cited by 228
Human psychoneuroimmunology: 20 Years of discovery
Irwin, M. R. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.07.013 · Cited by 231
Self-citationHerpes Zoster Recurrences More Frequent Than Previously Reported
Yawn, B. P., Wollan, P. C., Kurland, M. J., Sauver, J. L. S., & Saddier, P. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0618 · Cited by 224
A short history of vaccination
Plotkin, S. L., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00017-3 · Cited by 225
Grahn, A., & Studahl, M. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.06.004 · Cited by 221
Herpes Zoster in the Older Adult
John, A., & Canaday, D. H. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.016 · Cited by 220
Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
McDonald, J. R., Zeringue, A., Caplan, L., Ranganathan, P., Xian, H., Burroughs, T. E., Fraser, V. J., Cunningham, F., & Eisen, S. A. (2009) · Clinical Infectious Diseases · doi:10.1086/598331 · Cited by 218
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
Winthrop, K. L., MELMED, G. Y., Vermeire, S., Long, M. D., Chan, G. L., Pedersen, R. D., Lawendy, N., Thorpe, A. J., Nduaka, C. I., & Su, C. G. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy131 · Cited by 213
Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia
Dworkin, R. H., Gnann, J. W., Oaklander, A. L., Raja, S. N., Schmader, K. E., & Whitley, R. J. (2008) · Journal of Pain · doi:10.1016/j.jpain.2007.10.008 · Cited by 212
Self-citationIncidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease
Gupta, G., Lautenbach, E., & Lewis, J. D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.019 · Cited by 210
Vaccination of special populations: Protecting the vulnerable
Doherty, M., Schmidt-Ott, R., Santos, J. I., Stanberry, L. R., Hofstetter, A. M., Rosenthal, S. L., & Cunningham, A. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.015 · Cited by 208
van Wijck, A. J. M., Opstelten, W., Moons, K. G. M., van Essen, G. A., Stolker, R. J., Kalkman, C. J., & Verheij, T. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68032-x · Cited by 207
Leung, J. W. T., Harpaz, R., Molinari, N., Jumaan, A. O., & Zhou, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq077 · Cited by 206
Cunningham, A. L., Heineman, T. C., Lal, H., Godeaux, O., Chlíbek, R., Hwang, S., McElhaney, J. E., Vesikari, T., Andrews, C. P., Choi, W. S., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy095 · Cited by 205
Self-citationLangan, S., Smeeth, L. L., Margolis, D. J., & Thomas, S. L. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001420 · Cited by 203
Yih, W. K., Brooks, D. R., Lett, S. M., Jumaan, A. O., Zhang, Z. M., Clements, K. M., & Seward, J. F. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-68 · Cited by 202
Immunobiology of Varicella-Zoster Virus Infection
Laing, K. J., Ouwendijk, W. J. D., Koelle, D. M., & Verjans, G. M. G. M. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy403 · Cited by 202
Harbecke, R., Cohen, J. I., & Oxman, M. N. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab387 · Cited by 200
Self-citationIncidence of herpes zoster in patients with altered immune function
Chen, S.-Y., Suaya, J. A., Li, Q., Galindo, C. M., Misurski, D. A., Burstin, S. J., & Levin, M. J. (2013) · Infection · doi:10.1007/s15010-013-0550-8 · Cited by 198
Self-citationErard, V., Guthrie, K. A., Varley, C. D., Heugel, J., Wald, A., Flowers, M. E. D., Corey, L., & Boeckh, M. (2007) · Blood · doi:10.1182/blood-2007-03-077644 · Cited by 190
Herpes zoster and postherpetic neuralgia: prevention and management.
Mounsey, A., Matthew, L. G., & Slawson, D. C. (2005) · PubMed · Cited by 189
Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease
Long, M. D., Martin, C., Sandler, R. S., & Kappelman, M. D. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12182 · Cited by 186
Vaccination against Herpes Zoster and Postherpetic Neuralgia
Oxman, M. N., Levin, M. J., & Shingles Prevention Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/522159 · Cited by 180
Self-citationCiven, R., Chaves, S. S., Jumaan, A. O., Wu, H., Mascola, L., Gargiullo, P. M., & Seward, J. F. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a90b16 · Cited by 179
Stadtmauer, E. A., Sullivan, K. M., Marty, F. M., Dadwal, S., Papanicolaou, G. A., Shea, T. C., Mossad, S. B., Andreadis, C. B., Young, J. H., Buadi, F. K., et al. (2014) · Blood · doi:10.1182/blood-2014-04-573048 · Cited by 179
Quantification of risk factors for postherpetic neuralgia in herpes zoster patients
Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L. L., Clayton, T. C., Mansfield, K. E., Minassian, C., & Langan, S. (2016) · Neurology · doi:10.1212/wnl.0000000000002808 · Cited by 180
Metadata
- Authors
- Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, J. H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., Kauffman, C. A., Pachucki, C. T., Neuzil, K. M., Betts, R. F., Wright, P. F., Griffin, M. R., Brunell, P., Soto, N. E., Marques, A. R., Keay, S. K., Goodman, R. P., Cotton, D. J., Gnann, J. W., Loutit, J., Holodniy, M., Keitel, W. A., Crawford, G. E., Yeh, S.-S., Lobo, Z., Toney, J. F., Greenberg, R. N., Keller, P. M., Harbecke, R., Hayward, A. R., Irwin, M. R., Kyriakides, T. C., Chan, C. Y., Chan, I. S. F., Wang, W. W. B., Annunziato, P. W., & Silber, J. L.
- Affiliations
- University of California San Diego (US)
- Durham VA Medical Center (US)
- Duke Medical Center (US)
- National Institutes of Health (US)
- Washington University in St. Louis (US)
- VA Boston Healthcare System (US)
- VA NY Harbor Healthcare System (US)
- Columbia University (US)
- New Mexico VA Health Care System (US)
- National Institute of Allergy and Infectious Diseases (US)
- VA San Diego Healthcare System (US)
- VA Ann Arbor Healthcare System (US)
- Edward Hines, Jr. VA Hospital (US)
- VA Puget Sound Health Care System (US)
- University of Rochester Medicine (US)
- Vanderbilt University Medical Center (US)
- Baltimore VA Medical Center (US)
- VA Palo Alto Health Care System (US)
- Baylor College of Medicine (US)
- The University of Texas at San Antonio Health Science Center (US)
- Northport VA Medical Center (US)
- James A. Haley Veterans' Hospital (US)
- Lexington VA Health Care System (US)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-06-02
- Volume
- 352
- Issue
- 22
- Pages
- 2271-2284
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131041950
- Cited by
- 2,412
- References
- 40
- Citations by year
- 2026: 51 · 2025: 90 · 2024: 63 · 2023: 92 · 2022: 60 · 2021: 95 · 2020: 97 · 2019: 111 · 2018: 145 · 2017: 155 · 2016: 158 · 2015: 133 · 2014: 126 · 2013: 149 · 2012: 110
- FWCI
- 89.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- herpes zoster, postherpetic neuralgia, varicella-zoster virus, live attenuated zoster vaccine, older adults, vaccine efficacy, disease burden, cell-mediated immunity, injection site reactions
- MeSH terms
- Aged, Double-Blind Method, Female, Follow-Up Studies, Herpes Zoster, Humans, Immunologic Memory, Male, Middle Aged, Neuralgia, Vaccines, Attenuated, Herpesvirus 3, Human, Virus Activation, Incidence, Cost of Illness, Chickenpox Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
